Private & confidential
Dr. Chen Yajin
Chinese name: 陈亚进
Professor, Chief Physician, Doctoral Supervisor . Hepatobiliary Surgery
Dr. Yajin Chen is Director of Hepatobiliary Surgery and Director of General Surgery at Sun Yat-sen Memorial Hospital. A nationally renowned hepatobiliary and pancreatic surgeon, he was among the first in China to perform laparoscopic liver surgery and has led efforts to standardise minimally invasive techniques and enhanced recovery for liver cancer.

Dr. Chen Yajin
over 8,000
Laparoscopic hepatobiliary surgeries completed
more than 30
Years in hepatobiliary surgery
105
ALPPS procedures completed
About Dr. Chen Yajin
Dr. Yajin Chen is Director of Hepatobiliary Surgery and Director of General Surgery at Sun Yat-sen Memorial Hospital and an academic leader of the hepatobiliary discipline. He has devoted more than three decades to hepatobiliary and pancreatic surgery, and was among the first surgeons in China to perform laparoscopic liver resection. He has helped standardise laparoscopic techniques, indocyanine green fluorescence navigation and enhanced recovery protocols for liver cancer, and chairs national societies for enhanced recovery in hepatobiliary surgery. He is a recipient of the title China Famous Doctor and the Guangdong Physician Award.

1、Director of Hepatobiliary Surgery and Director of General Surgery at Sun Yat-sen Memorial Hospital
2、Academic leader of the hepatobiliary surgery discipline
3、Chairman of the Enhanced Recovery After Surgery Committee of the International Hepato-Pancreato-Biliary Association China Chapter
4、Standing committee member of the Surgeons Branch of the Chinese Medical Doctor Association
5、Recipient of the title China Famous Doctor and the Guangdong Physician Award
6、Among the first surgeons in China to perform laparoscopic liver resection
Dr. Chen Yajin ’s Three Key Areas of Expertise
Three areas of focused expertise, each supported by a deep subspecialty team, high case volumes and an English-speaking care pathway coordinated by Orisene.
Laparoscopic liver surgery
He performs laparoscopic and minimally invasive resection of liver tumours, including complex segmentectomy and anatomical resection with indocyanine green fluorescence navigation, achieving precise oncological clearance with less trauma, faster recovery and excellent long-term oncological outcomes for patients with hepatocellular carcinoma.
Hepatobiliary and pancreatic tumours
He treats liver, gallbladder, bile duct and pancreatic tumours, integrating surgery, systemic therapy and multidisciplinary care to select the best treatment for each patient, including conversion therapy and staged resection for advanced or borderline-resectable disease, improving survival and quality of life.
Gallbladder and biliary disease
He manages gallbladder carcinoma, gallstones, bile duct stones and pancreaticobiliary maljunction, using laparoscopic and minimally invasive techniques to remove disease safely, preserve organ function and reduce early recurrence and serious complications for patients living with benign and malignant biliary disorders.
More:liver cancer——conversion therapy; bile duct stones——minimally invasive surgery; pancreatic tumour——resection; enhanced recovery——perioperative care; liver cirrhosis——surgical management
Selected cases, research & publications
Representative work drawn from documented clinical treatments, publicly indexed literature, and hospital project records, reflecting the depth of this physician's hands-on expertise and academic rigor.
1. Laparoscopic Liver Resection for Liver Cancer
Professor Chen introduced laparoscopic liver resection to South China in 1998, one of the earliest in the country. Using keyhole surgery, he removes liver tumours with less bleeding and faster recovery than open surgery. This approach now benefits many liver cancer patients and has been standardised across Chinese hospitals.
Related link: https://www.gzsys.org.cn/node/15238
2. Asia’s First Laparoscopic-Assisted ALPPS Surgery
In 2013 Professor Chen’s team performed Asia’s first laparoscopic-assisted ALPPS, a two-stage operation for huge liver tumours when the remaining liver is too small. The procedure triggers rapid liver growth between stages, giving liver cancer patients who were previously inoperable a chance at curative resection.
3. Double Conversion Strategy for Advanced Liver Cancer
Professor Chen proposed internationally the double conversion concept, combining drugs and local treatments to shrink advanced liver cancer and enlarge the future liver remnant. This strategy converts some inoperable liver cancer into resectable disease, improving survival for patients with large or borderline tumours who once had few options.
Related link: https://topics.gmw.cn/2026-06/26/content_38842798.htm
4. Enhanced Recovery after Hepatobiliary Surgery
As a leader in enhanced recovery after surgery, Professor Chen promotes protocols that let liver and pancreatic cancer patients eat, move and leave hospital sooner after minimally invasive operations. These pathways reduce complications and cost while keeping surgical safety, and are now shared with hepatobiliary centres nationwide.
Related link: https://www.gzsys.org.cn/article/18523
5. Targeted Therapy for Advanced Liver Cancer
Professor Chen’s team tested Sitravatinib, a drug targeting the TYRO3 pathway, in advanced hepatocellular carcinoma. One patient with advanced liver cancer achieved near-complete remission with progression-free survival beyond two years. The finding supports new targeted options for liver cancer patients who cannot undergo surgery.
Related link: https://www.gzsys.org.cn/article/35011
6. Standardising Laparoscopic Liver Resection
Professor Chen’s group systematised laparoscopic hepatectomy for liver cancer, defining safe steps for segment and lobar resections and running national training courses. Their guidelines help surgeons in different-sized hospitals perform complex laparoscopic liver operations safely, expanding access to minimally invasive care for liver cancer patients.
Where Dr. Chen Yajin practices

Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Chinese name: 中山大学孙逸仙纪念医院
Sun Yat-sen Memorial Hospital, founded in 1835 as China's first Western hospital and now a Grade-A tertiary hospital, operates 3,013 beds with 5,700 staff, holding 17 national key specialties, 7 national key disciplines and four-organ transplant licenses, performing 150,000+ annual surgeries.
Since 1835
191 years of care
3,013
Licensed beds
150,000+
Annual surgeries
17
Licensed beds
Appointments with this physician are booked through official hospital channels only, coordinated end-to-end by Orisene.
Why patients travel to China for treatment
Six reasons international patients now put China on their shortlist — from internationally aligned clinical capability to the policy channels that make treatment here genuinely reachable.
Clinical capability at international standard
Chinese hospitals deliver internationally aligned protocols, performing vast volumes of advanced robotic, minimally invasive, and complex transplant surgeries annually. This massive clinical data and highly specialized workforce ensure world-class outcomes, even for rare and complex cases.
Diagnostics and treatment in days, not months
A full medical workup that typically means months of waiting elsewhere is completed in China within 48–72 hours. Imaging, labs, and multidisciplinary consultations are integrated into a single visit, allowing treatment to commence immediately.
Transparent, itemised pricing
Chinese healthcare offers legally binding, itemised cost estimates before treatment begins, eliminating hidden fees or surprise billing. Due to national centralized procurement, total expenses remain 40–70% lower than comparable care in Western Europe or North America.
Policy channels that open the door
China facilitates access through 240-hour visa-free transit and dedicated medical visa routes. Policies like the Greater Bay Area drug pathway and Boao Lecheng’s pilot zone allow designated hospitals to administer innovative therapies not yet globally approved.
Consulting this physician, step by step
From the first message to the follow-up after you fly home, one coordinator, no paperwork on your side.
01
Day 0
- Share your storyA private consultation with an Orisene advisor, by message, phone or video. Send medical records in any language. Nothing is shared with the hospital yet.
02
Days 1–3
- Records review & matchingOrisene translates and presents your case to the right specialist. The hospital returns a tailored care plan, with costs itemised once that plan is confirmed.
03
Days 3–7
- Your consultationAppointments are booked through official hospital channels only. Your navigator accompanies every visit with real-time interpretation, so you can focus on one thing: being cared for.
04
After you fly home
- Reports & follow-upTranslated reports and prescriptions delivered within days, remote follow-up coordination with your physicians at home, and a standing line to your navigator.
Orisene offers English and multilingual services, a professional medical interpreter at every consultation, plus translation of your records, reports and prescriptions.

Ready to plan your consultation with Dr. Chen Yajin?
Send your records in any language. An Orisene advisor will reply within 2 hours, present your case to the right specialist, and return a tailored care plan with itemised costs, before anything is booked. Simple. Private. Efficient.
Information Sources
This physician profile is compiled by the Orisene team from publicly available online sources and verified at the time of publication. Details may change, and physician availability is confirmed at the time of booking.
- Sun Yat-sen Memorial Hospital Official Expert Page: https://www.gzsys.org.cn/node/15238
- PubMed Author Records (laparoscopic and ICG-guided liver resection): https://pubmed.ncbi.nlm.nih.gov/42251213/
Disclaimer: This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal medical guidance.
Mention of any specific product, brand, or manufacturer is for informational purposes only and does not constitute an endorsement or recommendation by Dr. Chen Yajin.